Nancy Xiao

Director - Innovation, Research & Development Ferti Technologies

Nancy (Miyuan) Xiao, PhD is the Director of Innovation, Research & Development at Ferti Technologies Inc., where she leads the development and evaluation of specialty fertilizers, biostimulants, and next-generation agronomic technologies. With more than 15 years of experience in agricultural research and product innovation, she specializes in translating scientific findings into practical, commercially relevant solutions for growers and turf managers across North America. In her role, Nancy oversees collaborative university research programs spanning laboratory, greenhouse, and field trials, while supporting product commercialization, sustainability initiatives, and technical strategy. She earned her PhD from Cornell University and is recognized for bridging innovation, agronomy, sustainability, and market needs.

Seminars

Wednesday 31st March 2027
Advancing Soil Health Through Activated Biochar Technology: Driving Environmental and Social Sustainability
4:15 pm
  • Categorizing the Biological Landscape: A strategic framework defining where activated biochar fits within current agricultural biologicals, positioning it as a foundational catalyst for advancing overall soil health.
  • Driving Environmental and Social Sustainability with C2Charge: The agronomic mechanisms of activated biochar. A look at how the technology structurally improves soil metrics, optimizes nutrient retention, and supports long-term ecological balance.
Thursday 1st April 2027
Unlocking the Potential of Yeast Platforms to Accelerate Biological Product Innovation & Differentiate Next-Generation Biologicals
3:00 pm
  • Identify high-performing yeast strains and novel modes of action that expand the biological product toolbox beyond traditional bacterial and fungal solutions, enabling the development of differentiated products that address unmet crop protection and plant health challenges.
  • Leverage yeast-based fermentation platforms and scalable manufacturing processes to improve product consistency, shelf life, and commercial viability, reducing development risk and supporting successful scale-up from R&D to market.
  • Generate robust proof-of-concept, traceability, and field-performance data that demonstrate efficacy under real-world conditions, building grower confidence, accelerating market adoption, and strengthening product differentiation in a competitive biologicals landscape.
Nancy Xiao